{"acquisitions":[],"changes":[],"country":"NL","description":"TargED develops targeted thrombolytic drugs that use small VHH antibodies to deliver clot-dissolving enzymes directly to a thrombus. It targets patients with thrombotic disorders such as acute ischemic stroke and iTTP. Its differentiator is localized enzyme delivery that works regardless of clot composition.","domain":"targedbio.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":42.360413,"lng":-71.101828,"location":"Biopharmaceuticals","multiples":[],"name":"TargED Biopharmaceuticals B.V.","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":2700000,"connectionsAmong":[],"currency":"EUR","date":"2025-06-30","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"targedbio-com-2025-06-30-grant","source":{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-08","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"targedbio-com","sources":[{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-08","status":"attributed","url":null},{"fact":"existence","publisher":"targedbio.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://targedbio.com"},{"fact":"description","publisher":"targedbio.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://targedbio.com"}],"stage":null,"stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["WordPress","Yoast SEO 27.6","Underscore.js 1.13.8","Font Awesome","jQuery Migrate 3.4.1","jsDelivr","Varnish","OpenResty","Nginx","PHP","MySQL","jquery 3.7.1"],"totalRaisedUsd":5121400,"traction":[],"updatedAt":"2026-05-08","valuations":[]}